Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
36.9M
-
Shares change
-
-5.34M
-
Total reported value, excl. options
-
$43.2M
-
Value change
-
-$15.8M
-
Number of buys
-
32
-
Number of sells
-
-37
-
Price
-
$1.17
Significant Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q1 2016
90 filings reported holding CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2016.
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.9M shares
of 123M outstanding shares and own 29.99% of the company stock.
Largest 10 shareholders include Broadfin Capital, LLC (8.2M shares), BAKER BROS. ADVISORS LP (5.5M shares), FEDERATED INVESTORS INC /PA/ (5.09M shares), VANGUARD GROUP INC (3.12M shares), Point72 Asset Management, L.P. (2.26M shares), BlackRock Fund Advisors (1.96M shares), STATE STREET CORP (1.19M shares), BlackRock Institutional Trust Company, N.A. (1.09M shares), SPHERA FUNDS MANAGEMENT LTD. (905K shares), and NORTHERN TRUST CORP (764K shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.